Biostem Technologies
Logotype for Biostem Technologies Inc

Biostem Technologies (BSEM) investor relations material

Biostem Technologies M&A announcement summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Biostem Technologies Inc
M&A announcement summary22 Jan, 2026

Deal rationale and strategic fit

  • Acquisition of BioTissue's surgical and wound care business doubles addressable market, accelerates entry into acute wound care, and diversifies product offerings and revenue streams.

  • Complements legacy business by expanding product portfolio, extending geographic reach, and enhancing market position in advanced wound healing.

  • Provides access to both chronic and acute wound care markets, including hospital inpatient, outpatient, and ambulatory surgery centers, and expands access to major GPO networks.

  • Integration of an experienced national sales force and commercial infrastructure accelerates commercial expansion.

  • Aligns with long-term goals to build a market-leading advanced wound care business.

Financial terms and conditions

  • Upfront cash payment of approximately $15 million for all purchased and licensed assets, with up to $10 million in regulatory milestone payments and up to $15 million in commercial royalty milestone payments.

  • Acquired assets generated about $29 million in 2025 sales with gross margins of 65% and are expected to contribute positive EBITDA in 2026.

  • Post-closing cash and equivalents balance is approximately $16 million.

Synergies and expected cost savings

  • Integration of BioTissue's national sales force and GPO contracts strengthens presence in hospital and surgical settings and enhances operational efficiency.

  • Manufacturing and supply agreement with BioTissue for at least 12 months, followed by in-house production expected to expand gross margins.

  • Combined product suite and technology platforms anticipated to create synergies and broaden market access.

BioStem's cash post-acquisition is $16M. How will future milestone payments be funded?
How does this acquisition leverage BioStem's existing portfolio
Commercial integration plan for acquired sales force
How will CMS changes shift revenue mix by 2027?
Expected gross margin post-tech transfer?
What is the 510(k) pipeline product?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Biostem Technologies earnings date

Logotype for Biostem Technologies Inc
Q4 202513 Apr, 2026
Biostem Technologies
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Biostem Technologies earnings date

Logotype for Biostem Technologies Inc
Q4 202513 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

BioStem Technologies Inc. is a life sciences and regenerative medicine company that focuses on developing, manufacturing, and commercializing placental-derived allografts for advanced wound care. The company uses its proprietary BioRetain process to produce perinatal tissue allografts, preserving key biological properties that support tissue regeneration. BioStem’s products are used in a range of medical applications, including wound management and tissue repair. The company's portfolio includes products such as VENDAJE, VENDAJE AC, and AmnioWrap2. The company is headquartered in Pompano Beach, Florida, and its shares are listed on the OTC market.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage